Simplex Trading’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-58
| Closed | -$3K | – | 8315 |
|
|
2018
Q1 | $3K | Buy |
58
+10
| +21% | +$196 | ﹤0.01% | 5155 |
|
|
2017
Q4 | $11K | Sell |
48
-128
| -73% | -$2.35K | ﹤0.01% | 3862 |
|
|
2017
Q3 | $27K | Buy |
176
+120
| +214% | +$2.29K | ﹤0.01% | 2905 |
|
|
2017
Q2 | $7K | Sell |
56
-32
| -36% | -$473 | ﹤0.01% | 4374 |
|
|
2017
Q1 | $10K | Sell |
88
-4
| -4% | -$48 | ﹤0.01% | 4017 |
|
|
2016
Q4 | $6K | Buy |
+92
| New | +$1.57K | ﹤0.01% | 4278 |
|
|
2016
Q3 | – | Sell |
-470
| Closed | -$60K | – | 6898 |
|
|
2016
Q2 | $60K | Buy |
470
+451
| +2,374% | +$14.7K | ﹤0.01% | 1884 |
|
|
2016
Q1 | $3K | Buy |
19
+6
| +46% | +$211 | ﹤0.01% | 4598 |
|
|
2015
Q4 | $4K | Buy |
+13
| New | +$519 | ﹤0.01% | 4122 |
|
|
2015
Q3 | – | Sell |
-20
| Closed | -$3K | – | 6625 |
|
|
2015
Q2 | $3K | Buy |
20
+17
| +567% | +$807 | ﹤0.01% | 4178 |
|
|
2015
Q1 | $3K | Sell |
3
-248
| -99% | -$9.87K | ﹤0.01% | 3979 |
|
|
2014
Q4 | $66K | Buy |
+251
| New | +$7.35K | 0.01% | 1180 |
|
Simplex Trading's IPXL Position: Q3 2017 in Review
Simplex Trading sold out of Impax Laboratories, Inc. (IPXL) in Q3 2017, closing a stake of 12,708 shares — an estimated $243K sold.
Simplex Trading first reported a position in IPXL in Q1 2015 and held it in 7 quarters. The position peaked at $528K in Q1 2017. 189 funds tracked by Wall St. Rank hold IPXL as of Q3 2017.
- Simplex Trading reported no remaining Impax Laboratories, Inc. position as of Q3 2017 after selling out during the quarter.
- Simplex Trading sold 12,708 Impax Laboratories, Inc. shares in Q3 2017, an estimated $243K.
- Simplex Trading first reported a position in Impax Laboratories, Inc. in Q1 2015 and held it in 7 quarters.
- Simplex Trading's Impax Laboratories, Inc. position peaked at $528K in Q1 2017.
- 189 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2017.
Based on Simplex Trading's 13F filing for Q3 2017, filed 25 Oct 2017.